Bradmer provides clinical trial update and announces evaluation of strategic al...(ew product development uncertainties rel...),Health
Navigation Links
Bradmer provides clinical trial update and announces evaluation of strategic alternatives
Date:2/17/2009
ew product development, uncertainties related to the regulatory approval process and other risks detailed from time to time in the Company's ongoing quarterly and annual reporting.
'/>"/>
| SOURCE Bradmer Pharmaceuticals Inc. Copyright©2009 PR Newswire. All rights reserved |
Related medicine news :
1. Bradmer to participate in panel presentation at RBC Capital Markets Healthcare Conference
2. Bradmer to present poster on progression free survival and overall survival data from Neuradiab(TM) Phase II trials at Society for Neuro-Oncology Meeting
3. Bradmer announces 2008 third quarter operational and financial results
4. Bradmer to present at Rodman & Renshaw Healthcare Conference
5. Bradmer receives FDA approval to proceed with Phase III clinical trial
6. Bradmer announces 2008 first quarter operational and financial results
7. Bradmer announces new additions to management team
8. Bradmer announces 2007 fourth quarter and fiscal year operational and financial results
9. Notice of Bradmer Pharmaceuticals Conference Call
10. Bradmer announces Phase II results published in newly diagnosed glioblastoma which demonstrate improved survival and support upcoming Phase III study
11. Bradmer to present at the 10th Annual BIO CEO & Investor Conference
Post Your Comments:
Breaking Medicine News(10 mins):Health News:NCG Medical, Perfect Care EHR Achieves Preliminary ARRA 2011 Certification From CCHIT 2Health News:NCG Medical, Perfect Care EHR Achieves Preliminary ARRA 2011 Certification From CCHIT 3Health News:Clinical trial advances new approach to re-sensitizing breast cancer 2Health News:Mass Murderers: Why Do They Kill? 2
[0] Genomma Lab Announces Its 2010 Earnings Guidance[0] NCG Medical, Perfect Care EHR Achieves Preliminary ARRA 2011 Certification From CCHIT[0] Clinical trial advances new approach to re-sensitizing breast cancer[0] Many Stroke Survivors Don't Take Lifesaving Meds[0] Mass Murderers: Why Do They Kill?
Other Medicine News:Health News:Poniard Pharmaceuticals to Present at Needham & Company's Cancer Therapeutics: Today & Tomorrow Conference 2Health News:Anpath Group, Inc. Announces Intent To Seek Shareholder Approval for a Reverse Split of Its Common Stock 2Health News:The Department of Pain Medicine and Palliative Care at Beth Israel Medical Center is Named 2009 Center of Excellence Award Winner by the American Pain Society 2Health News:Class Action Filed Against South Florida Developer and Supplier of Defective Chinese Drywall 2Health News:Class Action Filed Against South Florida Developer and Supplier of Defective Chinese Drywall 3Health News:Frost & Sullivan Lauds Pioneer Surgical Technology for Development of Tissue Scaffold E-Matrix 2Health News:Frost & Sullivan Lauds Pioneer Surgical Technology for Development of Tissue Scaffold E-Matrix 3Health News:Frost & Sullivan Lauds Pioneer Surgical Technology for Development of Tissue Scaffold E-Matrix 4
Poniard Pharmaceuticals to Present at Needham & Company's Cancer Therapeutics: Today & Tomorrow ConferenceAnpath Group, Inc. Announces Intent To Seek Shareholder Approval for a Reverse Split of Its Common StockAbaxis, Inc. to Attend Lazard Capital Markets Medical Technologies ConferenceThe Department of Pain Medicine and Palliative Care at Beth Israel Medical Center is Named 2009 Center of Excellence Award Winner by the American Pain SocietyClass Action Filed Against South Florida Developer and Supplier of Defective Chinese DrywallFrost & Sullivan Lauds Pioneer Surgical Technology for Development of Tissue Scaffold E-Matrix
Breaking Medicine Technology:Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 2Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 3Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 4Boston Scientific Announces Pricing of $2 Billion of Senior Notes 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 3CORRECTION 3A Celebrate Your Family 58803 1CORRECTION 3A Celebrate Your Family 58803 2CORRECTION 3A Celebrate Your Family 58803 3CORRECTION 3A Celebrate Your Family 58803 4NIDDK announces availability of more current kidney disease data 58802 1NIDDK announces availability of more current kidney disease data 58802 2The real world of a forensic scientist 10247 1The real world of a forensic scientist 10247 2
Other Medicine Technology:New Data Highlight Positive Results of Namenda(R) (memantine HCl) Once-Daily Extended-Release Formulation 2New Data Highlight Positive Results of Namenda(R) (memantine HCl) Once-Daily Extended-Release Formulation 3New Data Highlight Positive Results of Namenda(R) (memantine HCl) Once-Daily Extended-Release Formulation 4Seattle's Swedish Cancer Institute First in U.S. to Treat Cancer Patient with Elekta VMAT 2Seattle's Swedish Cancer Institute First in U.S. to Treat Cancer Patient with Elekta VMAT 3Seattle's Swedish Cancer Institute First in U.S. to Treat Cancer Patient with Elekta VMAT 4
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |